Michelle Petri - Concepedia

Author

Michelle Petri

Also Known As

A. Petri, Michelle, Accelerating Medicines Partnership (AMP) Ra/sle, Accelerating Medicines Partnership in RA/SLE network, Alarcón, Graciela S, Andrea Fava, Andrew Liu, Anne Davidson, Betty Diamond, Carl Laskin, Engel, S.M.

983

Publications

72.7K

Citations

135

H-Index

242

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Oklahoma Medical Research Foundation University of Alabama at Birmingham University College London

About

Michelle Petri is an author at Johns Hopkins University specializing in medicine, lupus, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	63	129	16.1K
2	Public Health	21	26	3.1K
3	Health Sciences	6	6	379
4	Engineering	2	2	47
5	Social Sciences	2	2	89

Michelle Petri

463

Publications

61.5K

Citations

122

H-Index

Page 1

	Year	Citations
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus Michelle Petri, Ana‐Maria Orbai, Graciela S. Alarcón, Arthritis & Rheumatism	2012	5.1K
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial Sandra Navarra, Renato Guzmán, A Gallacher, The Lancet RheumatologyAutoimmune DiseaseLupusSystemic TreatmentLupus Nephritis	2011	2K
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus Richard Furie, Michelle Petri, Omid Zamani, Arthritis & Rheumatism	2011	1.6K
Mortality in systemic lupus erythematosus Sasha Bernatsky, J.‐F. Boivin, L. Joseph, Arthritis & Rheumatism	2006	1.2K
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus Michelle Petri, Mimi Kim, Kenneth Kalunian, New England Journal of Medicine	2005	1.1K
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis Ellen M. Ginzler, Mary Anne Dooley, Cynthia Aranow, New England Journal of Medicine	2005	1.1K
Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus Scott A. Jenks, Kevin S. Cashman, Esther Zumaquero, Immunity InflammationToll-like ReceptorsMolecular ImmunologyAutoimmune DiseaseSystemic Lupus Erythematosus	2018	1K
Association of Systemic Lupus Erythematosus with <i>C8orf13–BLK</i> and <i>ITGAM–ITGAX</i> Geoffrey Hom, Robert Graham, Barmak Modrek, New England Journal of Medicine	2008	911
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Annals of the Rheumatic Diseases	2023	766
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus Erythematosus Dafna D. Gladman, Murray B. Urowitz, Charles H. Goldsmith, Arthritis & Rheumatism	1997	749

Page 1